Laurus Labs Ltd - 540222 - Update On Composite Scheme Of Arrangement
Laurus Labs disclosed that the National Company Law Tribunal (NCLT) has directed September 10, 2026, as the next date for hearing its Composite Scheme of Arrangement. This scheme involves the demerger of Laurus Synthesis Private Limited's Unit-1 and amalgamation of the remaining business with Laurus Labs.
Jul 25 2026 17:09:40
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Laurus Labs reported strong Q1 FY27 results. Revenue increased 29% YoY to ₹2,026 Cr, while net profit surged 126% YoY to ₹368 Cr, primarily driven by robust growth in the CDMO segment.
Jul 24 2026 14:57:50
Laurus Labs Ltd - 540222 - Board Meeting Outcome for Outcome Of Board Meeting
Laurus Labs board approved Q1 FY27 cons. financial results on July 24, 2026. Revenue was ₹2,026.31 cr, up 29% YoY, and net profit was ₹361.99 cr, up 125% YoY. The meeting commenced at 2:00 PM IST and concluded at 2:42 PM IST.
Jul 24 2026 14:51:45
Laurus Labs Ltd - 540222 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2026
Laurus Labs' Board of Directors will meet on July 24, 2026, to consider and approve the financial results for the quarter ended June 30, 2026 (Q1 FY27).
Jul 09 2026 17:34:24
Read More